Thus, BC cell-derived Mstn likely binds to its heterodimeric receptor complex ActRIIA or IIB on the surface of progenitor cells and mature OCs, leading to subsequent activation of SMAD2 and ultimately to the expression of several OC-specific target genes. The gene discussed is ACVR2A; the disease is breast cancer.